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http://dx.doi.org/10.1016/j.gmbhs.20Abstract Helicobacter pylori commonly infects the human stomach lining is one of the risk
factors that can lead a gastric ulcer to develop into gastric cancer. Studies have found that
burdock can enhance the protection of gastrointestinal mucosa with antibacterial property
that can reduce the damage of the stomach by H pylori. Great burdock essence compounds
are prepared using a nanomicell formulation, which contains Arctium lappa Linn, Arnebia eu-
chroma, and Angelica sinensis. This study aims to assess the effectiveness of great burdock
essence compounds in the adjuvant treatment of H pylori infected clinical patients. Forty-
four patients with gastric ulcers, 21 of whom were taking great burdock essence compounds
and 23 taking placebo, were included in this study. After taking great burdock essence
compounds or placebo for 1 month, 13C-Urea Breath Test showed 20 (20/21) patients with
negative results and only one person with positive results among the burdock group; in addi-
tion, it also indicated that there were 1 6(16/23) with negative results and seven (7/23)
patients with positive results among the placebo group. The statistical results also showed that
the positive 13C-Urea Breath Test results in patients who took great burdock essenceMedical Research, Fooyin University Hospital, Number 5, Jhongshan Road, Donggang Township,
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an Genomic Medicine and Biomarker Society. Published by Elsevier Taiwan LLC. All rights reserved.
12.09.001
82 H.-C. Liu et al.compounds were significantly lower than that of the control group (p Z 0.027). It suggested
that great burdock essence is an appropriate health supplement for gastric ulcer patients with
H pylori infection.
Copyright ª 2012, Taiwan Genomic Medicine and Biomarker Society. Published by Elsevier
Taiwan LLC. All rights reserved.Introduction
Helicobacter pylori (H pylori), a gram-negative micro-
aerophilic bacterium first isolated from human gastric
mucosa by Marshall and Warren in 1982, is a type of
microaerophilic rod-shaped bacteria that commonly infects
the human stomach lining. More than one-half of the
world’s population have had H pylori infection.1,2 The adult
infection rate in Taiwan is about 54.4%. Generally, H pylori
infection happens in early childhood. If not treated,
H pylori will persist lifelong in the infected human stomach.
The infection is most likely transmitted orally through the
mouth during eating, and excreted out with feces. Thus,
the infection rate is closely related to the hygiene of the
living environment. In developing countries, its prevalence
in adults and children is quite high, reaching almost 80%e
90%.3e5 H pylori is one of the risk factors that can lead
a gastric ulcer to develop into gastric cancer. According to
the literature, groups with H pylori stomach infection are
at two to six times higher risk of having gastric cancer as
compared to groups that are uninfected. Epidemiologic
studies suggest that H pylori infection is directly related to
chronic atrophic gastritis, and it may develop into early
malignant lesions.6e8
Great burdock essence compounds are prepared using
a nanomicell formulation, which contains several major
components such as Arctium lappa Linn, Arnebia
euchroma, and Angelica sinensis. Arctium lappa Linn
belongs to a composite of herbaceous plants that contains
various ingredients such as inulin,9 polyphenols, and
chlorogenic acid. Studies have found that burdock can
enhance the protection of gastrointestinal mucosa with
antibacterial property that can reduce the damage of the
stomach by H pylori. It can also prevent mucosal damage
caused by alcohol. In addition, burdock also has anti-
mutagenic property, which lowers the possibility of
turning a gastrointestinal damage into cancer.10,11 The
main active ingredients in Arnebia euchroma include shi-
konin and naphthoquinone class compounds. Modern
studies have shown that shikonin possesses numerous
pharmacologic properties such as anti-inflammation, inhi-
bition of local acute inflammatory response, antitumor,
promotion of granulation tissue formation and wound
healing, inhibition of angiogenesis, inhibition of platelet
activity, inhibition of bacterial growth, and inhibition of
pathogenic fungi growth.12e14 The main active ingredient in
the angelica for the Umbelliferae is the ferulic acid, which
is an antioxidant capable of eliminating free radicals and
keeps them from doing tissue damage.15,16
The purpose of this study is to assess the effectiveness of
great burdock essence compounds in the adjuvant treat-
ment of H pylori infected clinical patients.Materials and methods
Participant recruitment and specimen collection
For the gastric ulcer patient information collected from
Fooyin University Hospital, the patients who show positive
Campylobacter-like organism (CLO) test results were
included. The exclusion criteria were the patients who have
congestive heart failure, chronic obstructive pulmonary
disease, serious systemic diseases and malignant tumors,
and patients with C13 breath test results <4/mil. Patients
were given antibiotics to take for a week in accordance
with the original treatment process. All the randomly given
great burdock essence compounds or placebos were taken
twice daily after morning and evening meals, each time
taken orally through a bottle (10 ml). They were taken
continuously for four weeks before tested for C13 breath
test results.Preparation of great burdock essence compounds
Preparation of burdock powder
Great burdock was provided by Dong Yuan Biotechnology
Pharmacy Co., Ltd (Kaohsiung, Taiwan). Take a burdock
plant and cut it into blocks before adding water to be
mixed. Then, heat it to 95 C and filter it twice while it is
still hot. Freeze dry the filtrate to obtain dried burdock
powder.
Arnebia euchroma and Angelica sinensis extraction
Prepare 90 g of Arnebia euchroma, 90 g of Angelica sinensis,
and 300 g of Sesame oil (Young Full Food Co., Ltd, Yunlin,
Taiwan). Arnebia euchroma, and Angelica sinensis were
purchased from traditional Chinese herb store. Place the
Chinese angelica in Sesame oil and soak it for 24 hours before
heating to 130-140 C. Then add the Arnebia euchroma, heat
it, and filter it before pouring the filtrate into the glass bottle
ready for use.
Burdock compound essence homogenization
Dissolve burdock powder in water until it has reached satu-
ration point and set it aside. Heat Lithospermum angelica
extract and glycerol using double boilingmethod to 80 C and
set them aside. Dissolve lecithin (Sigma-Aldrich Corporation,
MO, USA) in alcohol before placing double boiling. Wait until
alcohol evaporates before use. Sequentially add Arnebia
euchroma and Angelica sinensis extract, glycerine (Sigma-
Aldrich Co. LLC, USA), and burdock extract and mix well
before stirring at high-speed using a high-speed emulsion
homogenizer for about 3 minutes. Then, homogenize the
mixture in a high-pressure homogenizer (EmulsiFlex-C3,
Figure 1 13C-Urea Breath Test value distribution diagram of
burdock essence and placebo groups showing that the number
of people taking great burdock essence compounds with
13C-Urea Breath Test values 4/mil is 1 and <4/mil is 20; for
the placebo group, 4/mil is 7 and <4/mil is 16.
Burdock essence in Hp infected pts 83AVESTIN Inc., Ottawa, Canada). Finally, use a 0.1-mnada.
Finally, use a 0.1TIN Emulsi Flex-C3, x well before stirr.
Preparation of placebo
Placebo preparation method is much the same as that used
to prepare great burdock essence compounds, except that
water is used in place of Arctium lappa, Arnebia euchroma,
and Angelica sinensis ingredients.
CLO test
Use Pronto Dry reagent (Medical Instruments Corporation,
Solothurn, Switzerland) for urease test. Use a stomach
endoscope to obtain an appropriate amount of tissue and
place it on the test strip, and observe the color change. If
the color of the specimen changes from yellow to pink or
red within 24 hours, then it is positive; if it stays yellow,
then it is negative.
13C-urea breathe test
Participants had fasted for more than 8 hours and were given
13C-Urea labeled solution (75 mg). Air was blown into a gas
collection tube, which is analyzed through the Gas Chroma-
tography Isotope Ratio Mass Spectrometer (CIRMS) for 13C to
12C ratio. SinceHpylori contains largeamounts of urease, the
13C-Urea already taken is decomposed into 13C-carbon
dioxide (CO2) and ammonia (NH3), which are passed through
the blood to the trachea in the lungs to be exhaled. This is
used to determine whether participants have H pylori
infection. If GCIRMS test results 4, then it is determined as
positive.
Statistical analysis
Results were analyzed using SPSS software (SPSS Inc., Chi-
cago, IL, USA) and the positive / negative 13C-urea breathe
test results were analyzed using chi-square test. If the
analyzed results show a p < 0.05, then the difference is
significant.
Results
The study recruited a total of 44 patients, 21 of whom were
taking great burdock essence compounds and 23 were
taking placebo. The great burdock essence compounds
group included 13 men and 8 women, with an average age
of 46.80  9.65 (mean  standard deviation); the placeboTable 1 Clinical manifestation of burdock essence group
and placebo group.
Burdock essence
solution (N Z 21)
Placebo
(N Z 23)
Age (yrs) (mean  SD) 46.80  9.65 48.00  9.48
Sex
M 13 14
F 8 9
SD Z standard deviation.group included 14 men and nine women, with an average
age of 48.00  9.48 (mean  standard deviation; Table 1).
After taking great burdock essence compounds for 1
month, 13C-Urea Breath Test showed 20 patients with
negative results and one patient with positive results; the
placebo group showed 16 with negative results and seven
patients with positive results. The 13C-Urea Breath Test
value distribution diagram showed that the positive 13C-
Urea Breath Test results of the placebo group were signif-
icantly greater than that of the great burdock essence
compounds group (Fig. 1). Statistical results confirm that
the positive 13C-Urea Breath Test results in patients who
took great burdock essence compounds were significantly
lower than that of the control group (p Z 0.027; Table 2).
Discussion
The findings of this study demonstrated that one month
after consumption of Burdock essence, the gastric ulcer
condition of patients with H pylori infections was signifi-
cantly better than that of the control group (p Z 0.027).
This shows that Burdock essence is effective in inhibiting
the growth of H pylori virus. Burdock essence consists of
a mixed ingredient formula, including three Chinese herbs,
namely, Arctium lappa, Arnebia euchroma, and Angelica
sinensis. The active ingredient of Arctium lappa is chloro-
genic acid, one of the polyphenols commonly found in
foods. Past studies have shown that this substance is
bioactive and has multiple functions such as antioxidant,
anti-inflammatory, anti-cancer, antiulcer, and antiviral
effects.11,17e19 A study by Lou Z et al20 found that chloro-
genic acid increases the permeability of the outer andTable 2 13C-Urea Breath Test results from burdock
essence group and placebo group.
13C-Urea
Breath Test
Burdock essence
solution (N Z 21)
Placebo
(N Z 23)
p value
Negative (<4) 20 16 0.027*
Positive (4) 1 7
*p < 0.05 represents a statistically significant difference.
84 H.-C. Liu et al.plasma membrane of a virus, causing the virus to lose its
barrier protection and thus leading to its death.
The active ingredient of Arnebia euchroma is shikonin.
Studies have shown that shikonin and its derivatives have
antiviral effects against gram-positive viruses, gram-negative
viruses, and mold. Shikonin itself, however, is more effective
than its derivatives.13,21 Chen et al12 found that shikonin is
effective in controlling inflammatory responses. It blocks
regulated and normal T cells expressed and secreted
(RANTES) from combining with macrophage inflammatory
protein-1 alpha (MIP-1a) in monocytes. It can also block the
combination of RANTES and MIP-1a with CC chemokine
receptor-1 (CCR-1). In 1994, Ozaki et al14 found that shikonin
and acetylshikonin can enhance the growth of granuloma
tissues and that such growth is correlated with dosage.
The active ingredient of Angelica sinensis is ferulic acid,
which has antilipid peroxidation activities. It is a free
radical scavenger and may protect membrane lipids from
being harmed by free radicals. The chemical structure of
ferulic acid is such that its hydrogen atom can be easily
released to form a free radical with strong resonance or
high frequency stability. Unpaired electrons from peroxi-
dized structures may then be steadily transferred on to
ferulic acid, reducing the damage to the human body. The
transfer of unpaired electrons to ferulic acid can directly
eliminate free radicals and inhibit peroxidation responses
and free radical reactions.15 Ferulic acid can also inhibit
the formation of prostaglandin E2. It was found to signifi-
cantly control carrageenin-induced inflammatory responses
such as edema, vasodilation, and pain in mice.22
Burdock essence comprises three characteristics common
to Chinese herbs: antiviral, antioxidant, and anti-
inflammatory effects. In our past studies,23 it was found
that Burdock essence is effective in repairing the gastric
mucosa of gastric ulcer patients. In this study, however, it
was found that Burdock essence has anti-Hpylori properties.
In addition, patients with H pylori infections are usually
given a 3-in-1 combination treatment of proton pump
inhibitors, amoxicillin, and clarithromycin for one week.
According to J Wu et al,24 patients taking the 3-in-1 combi-
nation treatment have an approximately 90% success rate in
eradicating H pylori. This study found that the H pylori
eradication rate was even higher in patients taking Burdock
essence, at 95.2% (20/21). The H. pylori eradication rate of
the control group was approximately 69.6% (16/23). Burdock
essence has antiviral, antioxidant, and anti-inflammatory
properties and is an appropriate health supplement for
gastric ulcer patients with H pylori infection.
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